|
|
Article: Ocular Therapeutix, Inc. Appoints Two New Board Members.
- Article from:
- PR Newswire
- Article date:
- October 1, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WALTHAM, Mass., Oct. 1 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and Mr. Bernard Haffey.
Mr. Myers is currently the President, CEO and co-founder of Alimera Sciences, Inc., a biopharmaceutical company that is developing and commercializing prescription ophthalmic pharmaceuticals. Under his leadership, Alimera has raised venture funding totaling approximately $90M. Myers has over 25 years of experience in the ophthalmic pharmaceutical industry in sales, marketing, and general management. "I am pleased to have the opportunity to contribute to the Ocular Therapeutix ...